Figure 2
From: Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance
Abundance of plasma acylcarnitines during OGTT according to insulin sensitivity. (A) Log2-scaled, normalized UPLC-TOF-MS signal intensity of detected carnitine species according to quartile of insulin sensitivity (M/I) in boxplots (n = 470). (B) Difference in signal change 30–120 min between highest IR (M/I quartile 1, n = 117) and lowest IR (M/I quartile 4, n = 117) for different acylcarnitines.
